Skip to main content
JBM (Healthcare) Limited logo

JBM (Healthcare) Limited — Investor Relations & Filings

Ticker · 2161 HKEX Manufacturing
Open in API
Filings indexed 228 across all filing types
Latest filing 2025-11-03 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2161

About JBM (Healthcare) Limited

http://www.jbmhealthcare.com.hk

JBM (Healthcare) Limited is a developer, manufacturer, marketer, and distributor of branded healthcare and wellness products across Asia. The company's portfolio includes over-the-counter (OTC) products and proprietary Chinese medicines (PCMs), focusing on clinically substantiated and consumer-preferred brands. JBM emphasizes a shift from treatment to prevention and early intervention, aiming to enhance personal health and wellbeing for individuals and families throughout the region.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025
Share Issue/Capital Change Classification · 1% confidence The document is a standard monthly return filed to the Hong Kong Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised/registered share capital, issued shares, treasury shares, share options, warrants, convertibles, etc. It is not an AGM presentation, annual or interim report, earnings release or investor presentation. It specifically covers share capital movements, fitting the “Share Issue/Capital Change” (SHA) category rather than a generic regulatory announcement. Therefore, the appropriate filing type is SHA.
2025-11-03 English
JOINT ANNOUNCEMENT CONNECTED TRANSACTION AND CONTINUING CONNECTED TRANSACTION 2025 EUROPHARM LICENSE AGREEMENT
Regulatory Filings Classification · 1% confidence The document is a joint announcement made under the Hong Kong Listing Rules detailing a connected transaction and continuing connected transaction (the 2025 Europharm License Agreement) between related parties. It provides the principal terms, listing rules implications, annual caps, reasons, benefits, and internal controls. It is not an earnings release, financial report, prospectus, management discussion, nor a shareholder meeting material; rather, it is a regulatory announcement of a corporate transaction required under the Listing Rules. This type of announcement does not fall under other specific categories like AGM materials, director dealings, or financing updates. It is therefore classified as a general Regulatory Filing (RNS).
2025-10-28 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Exchanges and Clearing Limited under Chapter 19B of the Listing Rules, reporting movements in share capital and issued securities for the month ended. This is a routine regulatory filing rather than a financial report (10-K/IR), earnings release, or management presentation. It does not announce a meeting result, dividend, share issue event, or M&A, nor is it a transcript or audit report. It fits the catch-all category for miscellaneous regulatory submissions: Regulatory Filings (RNS).
2025-10-02 English
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is a formal announcement by JBM (Healthcare) Limited regarding the appointment of Dr. Xu as a non-executive director, including biographical details, terms of appointment, and board composition. This clearly falls under announcements of changes in the company’s board of directors, matching the definition for Board/Management Information.
2025-09-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 1% confidence The document is a list of the board of directors and their roles/functions on various Board committees, effective from a specified date. This is a direct announcement of board composition and committee assignments, which falls under Board/Management Information.
2025-09-30 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Share Issue/Capital Change Classification · 1% confidence The document is a Hong Kong Exchange Listing Rules Form FF301 – a Monthly Return for Equity Issuers on Movements in Securities. It details changes (or lack thereof) in authorised share capital, issued shares, treasury shares, share options, warrants, and convertibles. This is not an AGM, earnings, or management report but a regulatory filing specifically about share capital movements and issuance. Under our taxonomy, this aligns with Share Issue/Capital Change (SHA).
2025-09-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.